These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29979597)

  • 1. Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation.
    Singh V; Deepak RNVK; Sengupta B; Joshi AS; Fan H; Sen P; Thakur AK
    Mol Pharm; 2018 Aug; 15(8):3356-3368. PubMed ID: 29979597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Arginine Ethyl Ester as Polyglutamine Aggregation Inhibitor: Conformational Transitioning of Huntingtin N-Terminus Augments Aggregation Suppression.
    Singh V; Patel KA; Sharma RK; Patil PR; Joshi AS; Parihar R; Athilingam T; Sinha N; Ganesh S; Sinha P; Roy I; Thakur AK
    ACS Chem Neurosci; 2019 Sep; 10(9):3969-3985. PubMed ID: 31460743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of neurotoxic HTTex1 assemblies in human neurons.
    Chongtham A; Isas JM; Pandey NK; Rawat A; Yoo JH; Mastro T; Kennedy MB; Langen R; Khoshnan A
    Neurobiol Dis; 2021 Nov; 159():105517. PubMed ID: 34563643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1.
    Vieweg S; Mahul-Mellier AL; Ruggeri FS; Riguet N; DeGuire SM; Chiki A; Cendrowska U; Dietler G; Lashuel HA
    J Mol Biol; 2021 Oct; 433(21):167222. PubMed ID: 34492254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational dynamics and self-association of intrinsically disordered Huntingtin exon 1 in cells.
    Büning S; Sharma A; Vachharajani S; Newcombe E; Ormsby A; Gao M; Gnutt D; Vöpel T; Hatters DM; Ebbinghaus S
    Phys Chem Chem Phys; 2017 May; 19(17):10738-10747. PubMed ID: 28094373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation.
    Peskett TR; Rau F; O'Driscoll J; Patani R; Lowe AR; Saibil HR
    Mol Cell; 2018 May; 70(4):588-601.e6. PubMed ID: 29754822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity.
    Branco-Santos J; Herrera F; Poças GM; Pires-Afonso Y; Giorgini F; Domingos PM; Outeiro TF
    Hum Mol Genet; 2017 Oct; 26(19):3763-3775. PubMed ID: 28934390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable delivery system containing a peptide inhibitor of polyglutamine aggregation: a step toward therapeutic development in Huntington's disease.
    Joshi AS; Thakur AK
    J Pept Sci; 2014 Aug; 20(8):630-9. PubMed ID: 24788406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting.
    DeGuire SM; Ruggeri FS; Fares MB; Chiki A; Cendrowska U; Dietler G; Lashuel HA
    J Biol Chem; 2018 Nov; 293(48):18540-18558. PubMed ID: 30185623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core.
    Lin HK; Boatz JC; Krabbendam IE; Kodali R; Hou Z; Wetzel R; Dolga AM; Poirier MA; van der Wel PCA
    Nat Commun; 2017 May; 8():15462. PubMed ID: 28537272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Small Molecule Inhibitors of Huntingtin Exon 1 Aggregation by FRET-Based High-Throughput Screening in Living Cells.
    Lo CH; Pandey NK; Lim CK; Ding Z; Tao M; Thomas DD; Langen R; Sachs JN
    ACS Chem Neurosci; 2020 Aug; 11(15):2286-2295. PubMed ID: 32568514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.
    Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R
    J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale studies link amyloid maturity with polyglutamine diseases onset.
    Ruggeri FS; Vieweg S; Cendrowska U; Longo G; Chiki A; Lashuel HA; Dietler G
    Sci Rep; 2016 Aug; 6():31155. PubMed ID: 27499269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways.
    Moily NS; Ormsby AR; Stojilovic A; Ramdzan YM; Diesch J; Hannan RD; Zajac MS; Hannan AJ; Oshlack A; Hatters DM
    Mol Cell Neurosci; 2017 Sep; 83():103-112. PubMed ID: 28743452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.
    Arndt JR; Chaibva M; Legleiter J
    Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion.
    Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM
    J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and Structure of Wild Type Huntingtin Exon-1 Fibrils.
    Isas JM; Langen A; Isas MC; Pandey NK; Siemer AB
    Biochemistry; 2017 Jul; 56(28):3579-3586. PubMed ID: 28621522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.
    Trepte P; Strempel N; Wanker EE
    Essays Biochem; 2014; 56():167-80. PubMed ID: 25131594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy.
    Reif A; Chiki A; Ricci J; Lashuel HA
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 30010666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.